Composite Ceramic Bone Graft Substitute in the Treatment of Locally Aggressive Benign Bone Tumours

Abstract

Purpose.

To report the use of a composite ceramic bone graft substitute containing calcium sulphate and hydroxyapatite (HA) in the treatment of large expansive osteolytic benign bone tumours.

Methods.

4 women and 9 men aged 8 to 49 (mean, 22) years with aneurysmal bone cysts (n=6) or giant cell tumours (n=7) in the epi- or meta-physeal areas of the lower limbs underwent curettage, phenolisation, and filling with bone graft substitute containing calcium sulphate and HA. The mean tumour size was 38.5 (range, 18–65) ml. The patients were followed up for a mean of 41 (range, 33–52) months. Range of movement, Musculoskeletal Tumor Society Rating Score (MTSRS), and haematological and blood biochemical parameters were measured.

Results.

Two patients had recurrence at 7 and 9 months, both progressed to grade-III giant cell tumours. One underwent revision with an iliac crest autograft, whereas the other underwent en bloc excision and prosthetic replacement. The 11 other lesions displayed clinical and radiological consolidation at a mean of 4.6 (range, 3–7) months. No restriction of range of movement was observed, except in the patient undergoing prosthetic replacement. The mean MTSRS was 96% (range, 83–100%) of that expected for normal function. During the follow-up period, haematological and blood biochemical parameters stayed within normal limits.

Conclusion.

Composite bioceramic osteoconductive grafts, which combine porous HA with calcium sulphate, provide a framework for human osteogenesis and avoid donor-site morbidity (autologous bone graft harvesting). Tumour recurrence remains a major concern especially in young patients, as revision invariably requires removal of additional bone, potentially compromising joint integrity.

Keywords

bone cysts,aneurysmal bone neoplasms bone substitutes giant cell tumor of bone

References

Capanna

Sudanese

Baldini

Campanacci

. Phenol as an adjuvant in the control of local recurrence of benign neoplasms of bone treated by curettage. Ital J Orthop Traumatol 1985;11:381–8.

Lane

. Liquid nitrogen as an adjunct. Chir Organi Movi 1990;75(Suppl 1):S198–9.

Rock

. Adjuvant management of benign tumors; basic concepts of phenol and cement use. Chir Organi Movi 1990;75(Suppl 1):S195–7.

Schiller

Ritschl

Windhager

Kropej

Kotz

. The incidence of recurrence in phenol treated and non-phenol treated bone cavities following intralesional resection of non-malignant bone tumors [in German]. Z Orthop Ihre Grenzgeb 1989;127:398–401.

Marcove

Sheth

Takemoto

Healey

. The treatment of aneurysmal bone cyst. Clin Orthop Relat Res 1995;311:157–63.

Bitzan

Windhager

Lang

Richling

Kotz

. Incidence of recurrence of aneurysmal bone cysts following surgical treatment and adjuvant therapy with phenol [in German]. Z Orthop Ihre Grenzgeb 1995;133:422–8.

Malawer

Bickels

Meller

Buch

Henshaw

Kollender

. Cryosurgery in the treatment of giant cell tumor. A long-term follow-up study. Clin Orthop Relat Res 1999;359:176–88.

Agerholm

Goodfellow

. Simple bone cysts of the humerus treated by radical excision. J Bone Joint Surg Br 1965;47:714–7.

Neer

2nd Francis

Marcove

Terz

Carbonara

. Treatment of unicameral bone cyst. A follow-up study of one hundred seventy-five cases. J Bone Joint Surg Am 1966;48:731–45.

10.

Younger

Chapman

. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192–5.

11.

Gitelis

. Current concepts of treatment of bone tumors: Giant-cell tumor: Staging and treatment. In: Schajowicz

, editor. Tumors and tumorlike lesions of bone: Pathology, radiology and treatment. New York: Springer-Verlag; 1994:613–43.

12.

Pals

Wilkins

. Giant cell tumor of bone treated by curettage, cementation, and bone grafting. Orthopedics 1992;15:703–8.

13.

O'Donnell

Springfield

Motwani

Ready

Gebhardt

Mankin

. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am 1994;76:1827–33.

14.

Komiya

Inoue

. Cementation in the treatment of giant cell tumor of bone. Arch Orthop Trauma Surg 1993;112:51–5.

15.

Persson

Wouters

. Curettage and acrylic cementation in surgery of giant cell tumors of bone. Clin Orthop Relat Res 1976;120:125–33.

16.

Persson

Ekelund

Lovedahl

Gunterberg

. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand 1984;55:209–14.

17.

Cockin

. Autologous bone grafting complications at the donor site. J Bone Joint Surg Br 1971;53:153.

18.

Coventry

Tapper

. Pelvic instability: A consequence of removing iliac bone for grafting. J Bone Joint Surg Am 1972;54:83–101.

19.

Michanie

Cosentino

Baptista

Biagini

. Autoplastic grafting from the iliac wing: Surgical technique, indications and complications. Chir Organi Mov 1992;77:281–8.

20.

Damien

Parsons

Benedict

Weisman

. Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteoinductive factor. J Biomed Mater Res 1990;24:639–54.

21.

Damien

Parsons

. Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 1991;2:187–208.

22.

Burwell

. History of bone grafting and bone substitutes with special reference to osteogenic induction. In: Urist

O'Connor

Burwell

, editors. Bone grafts, derivatives and substitutes. Oxford: Butterworth Heinemann; 1994:3–102.

23.

Dreesmann

. Über Knochenplombierung. Beitr Klin Chir 1892;9:804–10.

24.

Stachow . Versuch über Knochenplombierung bei höhlenförmigen Defekten des Knochens. Beitr Klin Chir 1894;12:389–408.

25.

Albee

. Studies in bone growth: Triple calcium phosphate as a stimulus to osteogenesis. Ann Surg 1920;71:32–9.

26.

Bucholz

. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 2002;395:44–52.

27.

Oehlecker

. Über Knochenplombe. Zentralbl Chir 1925;52:993.

28.

Nielson

. Filling of sterile and infected bone cavities by means of plaster of Paris. Acta Chir Scand 1944;91:17–27.

29.

Hauptli

. Plaster filling in replacing missing bone tissue [in German]. Schweiz Med Wochenschr 1952;82:161–8.

30.

Peltier

. The use of plaster of Paris to fill defects in bone. Clin Orthop 1961;21:1–31.

31.

Tarsoly

. Filling of bone cavities with egg shell-plaster mixture [in German]. Acta Chir Acad Sci Hung 1963;4:63–72.

32.

Kelly

Wilkins

Gitelis

Hartjen

Watson

Kim

. The use of a surgical grade calcium sulfate as a bone graft substitute: Results of a multicenter trial. Clin Orthop Relat Res 2001;382:42–50.

33.

Peltier

Jones

. Treatment of unicameral bone cysts by curettage and packing with plaster-of-Paris pellets. J Bone Joint Surg Am 1978;60:820–2.

34.

Peltier

Bickel

Lillo

Thein

. The use of plaster of Paris to fill defects in bone. Ann Surg 1957;146:61–9.

35.

MacKey

Varlet

Debeaumont

. Antibiotic loaded plaster of Paris pellets: An in vitro study of a possible method in local antibiotic therapy in bone infection. Clin Orthop Relat Res 1982;167:263–8.

36.

Sidqui

Collin

Vitte

Forest

. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biometerials 1995;16:1327–32.

37.

Holmes

Wardrop

Wolford

. Hydroxylapatite as a bone graft substitute in orthognathic surgery: Histologic and histometric findings. J Oral Maxillofac Surg 1988;46:661–71.

38.

Boone

Zimmerman

Gutteling

Lee

Parsons

Langrana

. Bone attachment to hydroxyapatite coated polymers. J Biomed Mater Res 1989;23(A2 Suppl):S183–99.

39.

Furlong

Osborn

. Fixation of hip prostheses by hydroxyapatite ceramic coatings. J Bone Joint Surg Br 1991;73:741–5.

40.

Bucholz

Carlton

Holmes

. Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop Relat Res 1989;240:53–62.

41.

Salyer

Hall

. Porous hydroxyapatite as an onlay bone-graft substitute for maxillofacial surgery. Plast Reconstr Surg 1989;84:236–44.

42.

Heise

Osborn

Duwe

. Hydroxyapatite ceramic as a bone substitute. Int Orthop 1990;14:329–38.

43.

Costantino

Friedman

Jones

Chow

Pelzer

Sisson

Sr . Hydroxyapatite cement. I. Basic chemistry and histologic properties. Arch Otolaryngol Head Neck Surg 1991;117:379–84.

44.

Friedman

Costantino

Jones

Chow

Pelzer

Sisson

Sr . Hydroxyapatite cement. II. Obliteration and reconstruction of the cat frontal sinus. Arch Otolaryngol Head Neck Surg 1991;117:385–9.

45.

Inoue

Ibaraki

Shimabukuro

Shingaki

. Packing with high-porosity hydroxyapatite cubes alone for the treatment of simple bone cyst. Clin Orthop Relat Res 1993;293:287–92.

46.

Levai

Boisgard

. Acetabular reconstruction in total hip revision using a bone graft substitute. Early clinical and radiographic results. Clin Orthop Relat Res 1996;330:108–14.

47.

Ogose

Hotta

Kawashima

Kondo

Kamura

. Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitute after excision of bone tumors. J Biomed Mater Res B Appl Biomater 2005;72:94–101.

48.

Urist

. Bone: Formation by autoinduction. Science 1965;150:893–9.

49.

Urist

DeLange

Finerman

. Bone cell differentiation and growth factors. Science 1983;220:680–6.

50.

Nilsson

Urist

. Response to the rabbit metaphysis to implants of bovine bone morphogenetic protein (bBMP). Clin Orthop Relat Res 1985;195:275–81.

51.

Muthukumaran

Reddi

. Bone matrix-induced local bone induction. Clin Orthop Relat Res 1985;200:159–64.

52.

Reddi

Wientroub

Muthukumaran

. Biologic principles of bone induction. Orthop Clin North Am 1987;18:207–12.

53.

Urist

Nilsson

Rasmussen

Hirota

Lovell

Schmalzreid

. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop Relat Res 1987;214:295–304.

54.

Ekelund

Brosjo

Nilsson

. Experimental induction of heterotopic bone. Clin Orthop Relat Res 1991;263:102–12.

55.

Mohan

Baylink

. Bone growth factors. Clin Orthop Relat Res 1991;263:30–48.

56.

Murali

Porter

Gregory

Marshall

Aspden

McHardy

. New bone formation in an osteoporotic patient treated by intraosseous injection of bioactive materials: A case report. Cell Mater 1994;4:337–46.

57.

Najjar

Lerdrit

Parsons

. Enhanced osseointegration of hydroxyapatite implant material. Oral Surg Oral Med Oral Pathol 1991;71:9–15.

58.

LeGeros

. Properties of osteoconductive biomaterials: Calcium phosphates. Clin Orthop Relat Res 2002;395:81–98.

59.

Vaccaro

. The role of osteoconductive scaffold in synthetic bone graft. Orthopedics 2002;25(5 Suppl):S571–8.

60.

Shors

Holmes

. Bone formation in porous hydroxyapatite obtained from human biopsies. Bioceramics 1993;6:375–9.

61.

Pollick

Shors

Holmes

Kraut

. Bone formation and implant degradation of coralline porous ceramics placed in bone and ectopic sites. J Oral Maxillofac Surg 1995;53:915–23.

62.

Yamamoto

Onga

Marui

Mizuno

. Use of hydroxyapatite to fill cavities after excision of benign bone tumours. Clinical results. J Bone Joint Surg Br 2000;82:1117–20.

63.

Jamshidi

Swaim

. Bone marrow biopsy with unaltered architecture: A new biopsy device. J Lab Clin Med 1971;77:335–42.

64.

Campanacci

Baldini

Boriani

Sudanese

. Giant-cell tumor of bone. J Bone Joint Surg Am 1987;69:106–14.

65.

Enneking

Dunham

Gebhardt

Malawar

Pritchard

. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993;286:241–6.

66.

Schindler

Cannon

Briggs

Blunn

. Stanmore custom-made extendible distal femoral replacements. Clinical experience in children with primary malignant bone tumours. J Bone Joint Surg Br 1997;79:927–37.

67.

Schindler

Cannon

Briggs

Blunn

Grimer

Walker

. Use of extendable total femoral replacements in children with malignant bone tumours. Clin Orthop Relat Res 1998;357:157–70.

68.

Habal

Reddi

. Bone grafts and bone induction substitutes. Clin Plast Surg 1994;21:525–42.

69.

Rawlings

3rd Wilkins

Hanker

Georgiade

Harrelson

. Evaluation in cats of a new material for cranioplasty: A composite of plaster of Paris and hydroxylapatite. J Neurosurg 1988;69:269–75.

70.

Peltier

. The use of plaster of Paris to fill large defects in bones. Am J Surg 1959;97:311–5.

71.

Gitelis

Piasecki

Turner

Haggard

Charters

Urban

. Use of a calcium sulfate-based bone graft substitute for benign bone lesions. Orthopedics 2001;24:162–6.

72.

Uchida

Araki

Shinto

Yoshikawa

Kurisaki

Ono

. The use of calcium hydroxyapatite ceramic in bone tumour surgery. J Bone Joint Surg Br 1990;72:298–302.

73.

Galois

Mainard

Delagoutte

. Beta-tricalcium phosphate ceramic as a bone substitute in orthopaedic surgery. Int Orthop 2002;26:109–15.

74.

Hirata

Murata

Takeshita

Sakabe

Tsuji

Kubo

. Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours. Int Orthop 2006;30:510–3.

75.

Blaha

. Calcium sulfate bone-void filler. Orthopedics 1998;21:1017–9.

76.

Piecuch

Goldberg

Shastry

Chrzanowski

. Compressive strength of implanted porous replamineform hydroxyapatite. J Biomed Mater Res 1984;18:39–45.

77.

Hamson

Toth

Stiehl

Lynch

. Preliminary experience with a novel model assessing in vivo mechanical strength of bone grafts and substitute materials. Calcif Tissue Int 1995;57:64–8.

78.

Biesecker

Marcove

Huvos

Mike

. Aneurysmal bone cysts. A clinicopathologic study of 66 cases. Cancer 1970;26:615–25.

79.

Goldenberg

Campbell

Bonfiglio

. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J. Bone Joint Surg Am 1970;52:619–64.

80.

Sung

Kuo

Shu

Chai

Liu

. Giant-cell tumor of bone: Analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am 1982;64:755–61.

81.

Freiberg

Loder

Heidelberger

Hensinger

. Aneurysmal bone cysts in young children. J Pediatr Orthop 1994;14:86–91.

82.

Ghert

Rizzo

Harrelson

Scully

. Giant-cell tumour of the appendicular skeleton. Clin Orthop Relat Res 2002;400:201–10.

83.

Nicholson

Ramp

Kneisl

Kaysinger

. Hydrogen peroxide inhibits giant cell tumour and osteoblast metabolism in vitro. Clin Orthop Relat Res 1998;347:250–60.

84.

Lewis

Wei

Mendoza

Primus

Peabody

Simon

. Argon beam coagulation as an adjuvant for local control of giant cell tumor. Clin Orthop Relat Res 2007;454:192–7.

85.

Turcotte

Wunder

Isler

Bell

Schachar

Masri

. Giant cell tumor of long bone: A Canadian Sarcoma Group study. Clin Orthop Relat Res 2002;397:248–58.

86.

Masui

Ushigome

Fujii

. Giant cell tumor of bone: An immunohistochemical comparative study. Pathol Int 1998;48:355–61.

87.

Masui

Ushigome

Fujii

. Giant cell tumor of bone: A clinicopathologic study of prognostic factors. Pathol Int 1998;48:723–9.

88.

Rao

Bridge

Neff

Schaefer

Buehler

Vishwanatha

. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clin Exp Metastasis 1995;13:420–6.

89.

Younger

Chapman

. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192–5.